...
首页> 外文期刊>Journal of neuroendocrinology >Long-term central infusion of adiponectin improves energy and glucose homeostasis by decreasing fat storage and suppressing hepatic gluconeogenesis without changing food intake.
【24h】

Long-term central infusion of adiponectin improves energy and glucose homeostasis by decreasing fat storage and suppressing hepatic gluconeogenesis without changing food intake.

机译:长期集中输注脂联素可通过减少脂肪储存并抑制肝糖异生而改善能量和葡萄糖稳态,而无需改变食物摄入量。

获取原文
获取原文并翻译 | 示例

摘要

Adiponectin is known to be an anti-diabetic adipocytokine. However, the action mechanism by which it produces this effect remains controversial. In the present study, we investigated the long-term central effect of adiponectin on energy homeostasis, peripheral insulin resistance, beta-cell function and mass in rats and aimed to determine the mechanism by which its effect was achieved. Intracerebroventricular infusion of adiponectin (50 ng/h) and artificial cerebrospinal fluid (CSF) was conducted by means of an osmotic pump for 4 weeks on nondiabetic rats and 90% pancreatectomised diabetic rats that were both fed 45% energy fat diets. After 4-weeks of treatment, i.c.v. adiponectin improved hypothalamic insulin/leptin signalling in nondiabetic and diabetic rats compared to i.c.v. CSF but it did not change the phosphorylation of AMP kinase (AMPK) in the hypothalamus. Adiponectin infusion decreased epididymal fats, representing visceral fat, by increasing energy expenditure and fat oxidation. During the euglycaemic hyperinsulinaemic clamp, i.c.v. adiponectin improved whole body insulin sensitivity and decreased hepatic glucose output in the hyperinsulinaemic state by attenuating hepatic insulin resistance. Central infusion of adiponectin did not modulate glucose-stimulated insulin secretion during the hyperglycaemic clamp compared to i.c.v. CSF infusion but it enhanced insulin sensitivity at a hyperglycaemic state. Although there were no changes in insulin secretion capacity, central adiponectin increased pancreatic beta-cell mass in nondiabetic and diabetic rats as a result of decreasing beta-cell death. In conclusion, long-term central infusion of adiponectin enhanced energy homeostasis by increasing energy expenditure via activating hypothalamic leptin and insulin signalling pathways but without potentiating AMPK signalling; it also improved glucose homeostasis by attenuating insulin resistance.
机译:已知脂联素是抗糖尿病的脂联细胞因子。但是,其产生这种作用的作用机制仍存在争议。在本研究中,我们调查了脂联素对大鼠能量稳态,外周胰岛素抵抗,β细胞功能和体重的长期中枢作用,并旨在确定实现其作用的机制。通过渗透泵对非糖尿病大鼠和90%全胰切除的糖尿病大鼠进行脑室内脂联素(50 ng / h)和人工脑脊液(CSF)的脑内输注,持续4周,均用45%能量脂肪饮食喂养。治疗4周后,与i.c.v.相比,脂联素改善了非糖尿病和糖尿病大鼠的下丘脑胰岛素/瘦素信号传导。脑脊液,但它并没有改变下丘脑中AMP激酶(AMPK)的磷酸化。通过增加能量消耗和脂肪氧化,脂联素输注减少了代表内脏脂肪的附睾脂肪。在正常血糖高胰岛素钳夹过程中脂联素可通过减轻肝胰岛素抵抗来改善全身胰岛素敏感性,并降低高胰岛素血症状态下的肝葡萄糖输出。与i.c.v.相比,在高血糖钳制过程中,中央输注脂联素不能调节葡萄糖刺激的胰岛素分泌。脑脊液输注,但在高血糖状态下可增强胰岛素敏感性。尽管胰岛素分泌能力没有变化,但由于减少了β细胞死亡,中枢脂联素增加了非糖尿病和糖尿病大鼠的胰腺β细胞质量。总之,脂联素的长期集中输注通过激活下丘脑瘦素和胰岛素信号通路增加能量消耗而增强了能量稳态,但没有增强AMPK信号传导。它还通过减弱胰岛素抵抗来改善葡萄糖体内稳态。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号